RBR-68j3f26
Not yet recruiting
Phase 3
Endometriosis treatment with Dienogest Monotherapy or Dienogest associated to Intrauterine Dispositive of Levonorgestrel - a randomized clinical trial
niversidade Estadual de Campinas0 sitesJuly 16, 2024
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversidade Estadual de Campinas
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women aged 18 to 45 years. Diagnosis of endometriosis by specific imaging examination ultrasound, magnetic resonance imaging (MRI). Present at study entry with complaints of pelvic pain and/or deep dyspareunia. Agree to the use of dienogest or levonorgestrel intrauterine device (LNG IUD). No contraindications to the use of levonorgestrel intrauterine device (LNG IUD). No desire for pregnancy during the one\-year study period
Exclusion Criteria
- •Asymptomatic women. Women who have not initiated sexual activity. Women with psychiatric or neurological disorders that compromise the ability to respond to the questionnaires developed such as schizophrenia, neurodegenerative disorders, severe depression. Women undergoing treatment for chronic systemic diseases that lead to painful symptoms fibromyalgia, interstitial cystitis, neuropathic pain. History of abdominal surgery hysterectomy, colectomy, exploratory laparotomy, complicated appendectomy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Dienogest a tablet used in the treatment of ovarian cystHealth Condition 1: N801- Endometriosis of ovaryCTRI/2020/04/024793KMC Manipal
Completed
Phase 1
Treatment of Endometriosis using the drug methotrexate associated with lipid substances that facilitate the action of medication at the site of the diseaseEndometriosisPelvic PainDysmenorrheaDyspareuniaSP2.006.022RBR-7jx2byjFaculdade de Medicina da Universidade de São Paulo - USP
Active, not recruiting
Not Applicable
GnRH-Agonisten-Therapie bei Frauen mit Endometriose der Stadien III-IV nach rASRM-Kriterien vor reproduktionsmedizinischen Techniken (IVF / ICSI) (GARTE-Studie) - GARTEWomen with endometriosis who have been diagnosed with Stages III -IV according to rASRM criteriaEUCTR2006-002547-83-DEDr. Peter Sydow
Completed
Not Applicable
A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese ParticipantsEndometriosisNCT04495855Bayer968
Terminated
Not Applicable
Comparing medical management with laparoscopic surgery for the treatment of deep endometriosisISRCTN94462049HS Grampian18